Your browser doesn't support javascript.
loading
Network meta analysis of first-line therapy for advanced EGFR mutation positive non-small-cell lung cancer: updated overall survival.
Farris, MeganS; Larkin-Kaiser, Kelly A; Scory, Tayler; Boyne, Devon; Wilner, Keith D; Pastel, Malaïka; Cappelleri, Joseph C; Ivanova, Jasmina I.
Affiliation
  • Farris M; Medlior Health Outcomes Research Ltd, Calgary, AB, T2C 5P9, Canada.
  • Larkin-Kaiser KA; Medlior Health Outcomes Research Ltd, Calgary, AB, T2C 5P9, Canada.
  • Scory T; Medlior Health Outcomes Research Ltd, Calgary, AB, T2C 5P9, Canada.
  • Boyne D; Cytel, Toronto, ON, M5J 2P1, Canada.
  • Wilner KD; Pfizer Inc, La Jolla, CA 92121, USA.
  • Pastel M; Pfizer Inc, New York, NY 10017, USA.
  • Cappelleri JC; Pfizer Inc, Groton, CT 06340, USA.
  • Ivanova JI; Pfizer Inc, New York, NY 10017, USA.
Future Oncol ; 16(36): 3107-3116, 2020 Dec.
Article in En | MEDLINE | ID: mdl-32869649

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Protein Kinase Inhibitors / Quinazolinones / Lung Neoplasms Type of study: Clinical_trials / Diagnostic_studies / Prognostic_studies / Systematic_reviews Limits: Humans Language: En Journal: Future Oncol Year: 2020 Document type: Article Affiliation country: Canada Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Protein Kinase Inhibitors / Quinazolinones / Lung Neoplasms Type of study: Clinical_trials / Diagnostic_studies / Prognostic_studies / Systematic_reviews Limits: Humans Language: En Journal: Future Oncol Year: 2020 Document type: Article Affiliation country: Canada Country of publication: United kingdom